The case of adherence in the youth: Rebel without a cause?

AIDS

Volumn 28, Issue 13, 2014, Pages 1983-1985

  Parienti, Jean Jacques ^a,b  

^a CHU CÔTE DE NACRE   (France)

^b UNIVERSITÉ DE CAEN   (France)

Author keywords

Adherence; Adolescent; Antiretroviral therapy; HIV AIDS; Meta analysis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ANTIVIRAL THERAPY; ANXIETY; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DEVELOPING COUNTRY; DOCTOR PATIENT RELATION; GROUPS BY AGE; HARM REDUCTION; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTERPERSONAL COMMUNICATION; JUVENILE; NOTE; POPULATION; PRIORITY JOURNAL; RECREATION; RNA REPLICATION; SEXUAL BEHAVIOR; SOCIAL STIGMA; SYSTEMATIC REVIEW (TOPIC); TEXT MESSAGING; TREATMENT REFUSAL; VIRUS LOAD;

HUMANS;

EID: 84906568275     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000317     Document Type: Note

References (17)

1. Kim S-H, Gerver SM, Fidler S, Ward H. Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis. AIDS 2014; 28:1945-1956.
2. Descamps D, Flandre P, Calvez V, Peytavin G, Meiffredy V, Collin G, et al. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team). JAMA 2000; 283:205-211.
3. Das M, Chu PL, Santos G-M, Scheer S, Vittinghoff E, McFarland W, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PloS One 2010; 5:e11068.
4. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
5. Parienti J-J, Massari V, Descamps D, Vabret A, Bouvet E, Larouzé B, et al. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenzbased antiretroviral therapy. Clin Infect Dis OffPubl Infect Dis Soc Am 2004; 38:1311-1316.
6. Siedner MJ, Musinguzi N, Tsai AC, Muzoora C, Kembabazi A, Weiser SD, et al. Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda. AIDS 2014; 28:267-271.
7. Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group. Sabin CA, Smith CJ, d' Arminio-Monforte A, Battegay M, Gabiano C, et al. Response to combination antiretroviral therapy: variation by age. AIDS 2008; 22:1463-1473.
8. Dollfus C, Le Chenadec J, Faye A, Blanche S, Briand N, Rouzioux C, et al. Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). Clin Infect Dis OffPubl Infect Dis Soc Am 2010; 51:214-224.
9. Jones DJ, Runyan DK, Lewis T, Litrownik AJ, Black MM, Wiley T, et al. Trajectories of childhood sexual abuse and early adolescent HIV/AIDS risk behaviors: the role of other maltreatment, witnessed violence, and child gender. J Clin Child Adolesc Psychol 2010; 53:667-68039.
10. Mimiaga MJ, Safren SA, Dvoryak S, Reisner SL, Needle R, Woody G. Wefear the police, and the police fear us': structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine. AIDS Care 2010; 22:1305-1313.
11. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006; 296:679-690.
12. Meresse M, March L, Kouanfack C, Bonono R-C, Boyer S, Laborde-Balen G, et al. Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon. HIV Med Published Online First: 2014. doi:10.1111/hiv.12140.
13. Parienti J-J, Bangsberg DR, Verdon R, Gardner EM. Better adherence with once-daily antiretroviral regimens: a metaanalysis. Clin Infect Dis Off Publ Infect Dis Soc Am 2009; 48:484-488.
14. Nachega JB, Parienti J-J, Uthman OA, Gross R, Dowdy DW, Sax PE, et al. Lower pill burden and once-daily antiretroviral treatment regimens for hiv infection: a meta-analysis of randomized controlled trials. Clin Infect Dis 2014. doi:10.1093/cid/ciu046.
15. Parienti J-J, Ragland K, Lucht F, de la Blanchardière A, Dargère S, Yazdanpanah Y, et al. Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication. Clin Infect Dis 2010; 50:1192-1197.
16. Usitalo A, Leister E, Tassiopoulos K, Allison S, Malee K, Paul ME, et al. Relationship between viral load and self-report measures of medication adherence among youth with perinatal HIV infection. AIDS Care 2014; 26:107-115.
17. Shubber Z, Calmy A, Andrieux-Meyer I, Vitoria M, Renaud-Théry F, Shaffer N, et al. Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis. AIDS 2013; 27:1403-1412.